CD4 and inflammatory bowel disease: LncITSN1-2 has been demonstrated that it promotes IBD CD4+ T cell activation, proliferation, and Th1/Th17 cell differentiation by serving as a ceRNA for IL-23R via sponging miR-125a in inflammatory bowel disease (IBD) (49).